Published in Medicine and Law Weekly, July 1st, 2005
The company believes that this patent provides a very different approach than those of other existing patents describing the measurement of HDL and that this patent also permits the development of the Cholestech LDX Lipid Profile/Alanine Aminotransferase (Lipid/ALT) cassette by preventing the interference of the HDL chemistry with the ALT assay on the same cassette.
Cholestech provides diagnostic tools and information to healthcare...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly